OOIR: Observatory of International Research

Papers

(The median citation count of Diabetes & Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Contents - page 1	100
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	81
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	74
Editorial board	50
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?	42
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial	41
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	38
Contents	36
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	36
Editorial board	35
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	34
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	33
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps	31
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes	31
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	30
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework	30
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	30
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study	30
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	29
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	26
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	26
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	26
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”	26
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	25
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	25

Concise review of lipidomics in nonalcoholic fatty liver disease	25
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes	24
Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)	24
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	24
1-h post-load plasma glucose for detecting early stages of prediabetes	23
Type B insulin resistance syndrome: A case report	23
Contents	21
Sommaire	20
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study	19
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018	18
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	18
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study	18
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin	17
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study	17
Averaged glycaemic variability or by average: More than a simple question of wording	16
Glucose management indicator: Do we need device-specific equations?	16
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT	16
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”	15
Editorial board	15
Peripheral neuropathy as a bedside marker for cerebral microangiopathy	15
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3	15
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	15
Diabetes prevalence, awareness, and control in the United States, 2017-2023	15
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	15
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study	15
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	14
Transitions in metabolic health status over time and risk of heart failure: A prospective study	14
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study	13
Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases	13
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	13
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes	12
Contents - Page 1	12
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation	12
Editorial board	12
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies	11
Contents	11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design	11
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention	11
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations	11
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy	11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease	11
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	11
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach	11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand	11
Glucagon like peptide-1 receptor agonists in type 1 diabetes	10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography	10
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance	10
Contents - page 1	10
Editorial board	10
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	10

Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer	10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders	10
Contents	9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	9
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	9
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report	9
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study	9
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults	9
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals	9
Diabetic ketoacidosis and mortality in COVID-19 infection	9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists	8
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION	8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus	8
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort	8
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan	8
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs	8
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes	8
Editorial board	8
Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study	8
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States	8
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme	7
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 2019	7
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead	7
The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation	7
SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients	7
Trajectories of social isolation and loneliness and the risk of incident type 2 diabetes mellitus across genetic risk score	7
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	7
Editorial board	7
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes	7
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	7
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch	7
Glycaemic variabilities: Key questions in pursuit of clarity	7
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study	7
Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their	7
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease	7
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study	7
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	7
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	7
Contents	7
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	7
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?	7
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study	6
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	6
Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry	6
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	6
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus	6
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment	6
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study	6
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	6
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass	6
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	6
Sommaire	5
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease	5
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)	5
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study	5
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	5
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	5
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database	5
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study	5
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease	5
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring	5
Editorial board	5
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	5
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus	5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists	5
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey	5
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity	5
Eye disorders other than diabetic retinopathy in patients with diabetes	5
Contents	5
Microalbuminuria screening in patients with ST-elevation myocardial infarction	5
Editorial board	4
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank	4
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	4
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study	4
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months	4
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks	4
Editorial board	4
Comment on Orsi et al. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes [Diabetes Metab, 2023 Mar, 101413]	4

Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease	4
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study	4
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study	4
Glucagon-like peptide-1 receptor agonists and acute pancreatitis	4
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss	4
Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study	4
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	4
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies	4
Editorial board	4
Editorial board	4
Editorial board	4
Management of patients with type 2 diabetes and MASLD: An overview and joint statement	4
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes	4
Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study	3
Smoking and diabetes interplay: A comprehensive review and joint statement	3
Variable incidence of ketoacidosis in youth with type 1 diabetes onset during COVID-19 pandemic peaks in France	3
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society	3
Key indices of glycaemic variability for application in diabetes clinical practice	3
Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort	3
Practical implementation of automated insulin delivery systems in 2025: A French position statement update	3
Contents	3
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial	3
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease	3
Self-reported haemoglobin A1c highly agrees with laboratory-measured haemoglobin A1c among adults living with type 1 diabetes: A BETTER registry study	3
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study	3
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes	3
Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study	3
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study	3
Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series	3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	3